Biotechnology
The Biotechnology industry has a total of 604 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.23 billion.
Market Cap
1.11T
Revenue
105.23B
Profits
-42.06B
PE Ratio
n/a
Profit Margin
-39.98%
Dividend Yield
0.04%
604 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.40B | 1.11% | 936,875 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.96B | -0.86% | 358,927 | 14.25B |
| 3 | ARGX | argenx SE | 54.11B | -1.26% | 151,894 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 51.28B | -5.92% | 953,400 | 3.21B |
| 5 | INSM | Insmed Incorporated | 41.74B | 0.24% | 895,379 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.30B | -0.58% | 88,734 | 4.97B |
| 7 | BNTX | BioNTech SE | 22.79B | -1.26% | 389,859 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.07B | -1.49% | 1,342,870 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.50B | -2.69% | 1,190,535 | 3.85B |
| 10 | INCY | Incyte Corporation | 18.47B | -2.12% | 1,087,412 | 4.81B |
| 11 | ROIV | Roivant Sciences Ltd. | 15.34B | 3.37% | 7,251,350 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 15.26B | 0.56% | 1,005,680 | - |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.34B | 0.48% | 773,716 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.46B | -2.95% | 904,941 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.05B | 0.60% | 81,029 | 740.64M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.00B | 1.38% | 678,956 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.85B | 0.06% | 263,563 | 758.59M |
| 18 | MRNA | Moderna, Inc. | 11.69B | 0.96% | 6,842,303 | 2.23B |
| 19 | EXEL | Exelixis, Inc. | 10.99B | -1.35% | 1,174,666 | 2.29B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.81B | 0.17% | 461,837 | 20.87M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.19B | 1.67% | 292,269 | 4.16B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.15B | -0.33% | 724,593 | 3.09B |
| 23 | ABVX | ABIVAX Société Anonyme | 9.60B | -4.31% | 1,041,312 | 7.07M |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.39B | -2.36% | 805,496 | 829.45M |
| 25 | CORT | Corcept Therapeutics Incorporated | 9.29B | 1.40% | 402,538 | 741.17M |
| 26 | TECH | Bio-Techne Corporation | 9.19B | -2.07% | 692,068 | 1.22B |
| 27 | NUVL | Nuvalent, Inc. | 8.18B | -0.50% | 258,874 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 7.66B | 3.09% | 664,980 | 87.21M |
| 29 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.61B | -3.10% | 1,276,686 | 174.33M |
| 30 | CAI | Caris Life Sciences, Inc. | 7.48B | -0.15% | 937,867 | 649.06M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 7.40B | -1.35% | 342,510 | 561.26M |
| 32 | MRUS | Merus N.V. | 7.35B | 0.30% | 429,418 | 56.61M |
| 33 | HALO | Halozyme Therapeutics, Inc. | 7.35B | 0.97% | 2,882,026 | 1.24B |
| 34 | KRYS | Krystal Biotech, Inc. | 7.10B | -0.72% | 163,439 | 373.16M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 7.06B | 0.43% | 725,487 | 43.74M |
| 36 | CDTX | Cidara Therapeutics, Inc. | 6.93B | 0.13% | 226,949 | 302.00K |
| 37 | PRAX | Praxis Precision Medicines, Inc. | 6.74B | 0.91% | 219,746 | 7.46M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.32B | 3.75% | 1,361,881 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 6.07B | 0.15% | 305,292 | 1.78B |
| 40 | PTGX | Protagonist Therapeutics, Inc. | 5.87B | 1.82% | 493,594 | 209.22M |
| 41 | PCVX | Vaxcyte, Inc. | 5.79B | -0.81% | 629,529 | - |
| 42 | CRSP | CRISPR Therapeutics AG | 5.43B | -1.89% | 839,335 | 38.34M |
| 43 | BLTE | Belite Bio, Inc | 5.35B | -5.01% | 133,038 | - |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.20B | 0.74% | 392,218 | - |
| 45 | CELC | Celcuity Inc. | 4.96B | 6.32% | 843,491 | - |
| 46 | TERN | Terns Pharmaceuticals, Inc. | 4.85B | -3.21% | 2,476,543 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.82B | 0.81% | 1,187,304 | - |
| 48 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.76B | 1.66% | 593,286 | 1.54M |
| 49 | ADMA | ADMA Biologics, Inc. | 4.73B | -2.45% | 1,332,829 | 488.56M |
| 50 | TGTX | TG Therapeutics, Inc. | 4.64B | -0.78% | 535,422 | 531.90M |
| 51 | IMVT | Immunovant, Inc. | 4.61B | 5.93% | 1,638,614 | - |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 4.51B | -0.07% | 463,099 | 1.05B |
| 53 | VKTX | Viking Therapeutics, Inc. | 4.22B | 0.43% | 1,657,366 | - |
| 54 | NAMS | NewAmsterdam Pharma Company N.V. | 4.18B | 1.95% | 363,923 | 35.24M |
| 55 | ACLX | Arcellx, Inc. | 4.17B | -0.81% | 308,781 | 35.90M |
| 56 | LEGN | Legend Biotech Corporation | 4.15B | -2.30% | 1,114,853 | 909.05M |
| 57 | GPCR | Structure Therapeutics Inc. | 4.15B | 1.44% | 690,418 | - |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.86B | -2.83% | 1,532,710 | 15.00M |
| 59 | ARQT | Arcutis Biotherapeutics, Inc. | 3.52B | -2.54% | 985,589 | 317.93M |
| 60 | TARS | Tarsus Pharmaceuticals, Inc. | 3.50B | 0.78% | 184,275 | 366.10M |
| 61 | RARE | Ultragenyx Pharmaceutical Inc. | 3.49B | 0.17% | 829,256 | 630.60M |
| 62 | VERA | Vera Therapeutics, Inc. | 3.48B | 6.67% | 889,590 | - |
| 63 | IRON | Disc Medicine, Inc. | 3.47B | -1.79% | 298,786 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.40B | 0.73% | 415,229 | 7.50M |
| 65 | MIRM | Mirum Pharmaceuticals, Inc. | 3.33B | -1.43% | 227,599 | 471.79M |
| 66 | CGON | CG Oncology, Inc. | 3.32B | -0.99% | 190,025 | 2.17M |
| 67 | APLS | Apellis Pharmaceuticals, Inc. | 3.15B | -0.34% | 652,525 | 1.02B |
| 68 | OCUL | Ocular Therapeutix, Inc. | 3.13B | 0.14% | 1,411,590 | 55.78M |
| 69 | TVTX | Travere Therapeutics, Inc. | 3.11B | -0.81% | 880,121 | 435.83M |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.10B | -3.95% | 149,906 | 664.23M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.10B | -0.21% | 564,383 | 70.79M |
| 72 | FOLD | Amicus Therapeutics, Inc. | 3.05B | -0.05% | 954,207 | 598.70M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.98B | 1.19% | 512,880 | 214.83M |
| 74 | MLYS | Mineralys Therapeutics, Inc. | 2.95B | 3.56% | 1,212,138 | - |
| 75 | LQDA | Liquidia Corporation | 2.90B | 2.36% | 516,675 | 69.22M |
| 76 | NUVB | Nuvation Bio Inc. | 2.90B | 2.30% | 3,032,149 | 26.75M |
| 77 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.88B | 2.09% | 818,662 | 578.20M |
| 78 | AAPG | Ascentage Pharma Group International | 2.80B | -1.63% | 405 | 54.52M |
| 79 | DYN | Dyne Therapeutics, Inc. | 2.78B | 0.26% | 1,420,945 | - |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 2.91% | 934,327 | 98.68M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.71B | -0.18% | 952,410 | 55.70M |
| 82 | WVE | Wave Life Sciences Ltd. | 2.70B | -3.58% | 5,129,827 | 109.23M |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.68B | -13.92% | 5,723,240 | 240.00M |
| 84 | DNLI | Denali Therapeutics Inc. | 2.63B | 3.05% | 677,414 | - |
| 85 | SYRE | Spyre Therapeutics, Inc. | 2.62B | -1.69% | 412,099 | - |
| 86 | EWTX | Edgewise Therapeutics, Inc. | 2.61B | 5.42% | 747,878 | - |
| 87 | OLMA | Olema Pharmaceuticals, Inc. | 2.61B | 4.91% | 1,632,928 | - |
| 88 | IBRX | ImmunityBio, Inc. | 2.42B | 12.33% | 19,870,991 | 82.56M |
| 89 | MESO | Mesoblast Limited | 2.37B | -1.14% | 172,799 | 17.20M |
| 90 | ADPT | Adaptive Biotechnologies Corporation | 2.33B | -0.84% | 906,220 | 252.75M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.30B | 0.91% | 364,752 | 825.94M |
| 92 | RXRX | Recursion Pharmaceuticals, Inc. | 2.27B | -4.59% | 12,355,812 | 43.69M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.26B | -0.64% | 1,159,689 | 2.41B |
| 94 | GLPG | Galapagos NV | 2.13B | -2.43% | 40,466 | 336.64M |
| 95 | ZBIO | Zenas BioPharma, Inc. | 2.12B | -1.91% | 132,219 | 15.00M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | -0.50% | 443,573 | 265.81M |
| 97 | ZLAB | Zai Lab Limited | 2.00B | 0.67% | 420,335 | 441.63M |
| 98 | NRIX | Nurix Therapeutics, Inc. | 1.95B | 0.84% | 670,708 | 83.69M |
| 99 | ZYME | Zymeworks Inc. | 1.93B | 3.25% | 367,153 | 134.48M |
| 100 | SION | Sionna Therapeutics, Inc. | 1.89B | 1.71% | 111,339 | - |
| 101 | MAZE | Maze Therapeutics, Inc. | 1.87B | -1.69% | 139,729 | 2.50M |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.87B | -1.03% | 429,557 | 205.63M |
| 103 | VCEL | Vericel Corporation | 1.85B | -2.06% | 213,449 | 258.72M |
| 104 | IMCR | Immunocore Holdings plc | 1.84B | 1.62% | 360,214 | 379.59M |
| 105 | MNKD | MannKind Corporation | 1.84B | 2.93% | 1,786,872 | 313.79M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.83B | -1.22% | 271,587 | 2.60M |
| 107 | DNTH | Dianthus Therapeutics, Inc. | 1.83B | 2.50% | 253,206 | 3.08M |
| 108 | IMNM | Immunome, Inc. | 1.79B | 0.21% | 566,874 | 9.68M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | -0.34% | 530,170 | 111.30M |
| 110 | SVRA | Savara Inc. | 1.67B | - | 1,846,023 | - |
| 111 | TRVI | Trevi Therapeutics, Inc. | 1.66B | -1.59% | 1,036,492 | - |
| 112 | TSHA | Taysha Gene Therapies, Inc. | 1.59B | 0.87% | 1,517,782 | 6.31M |
| 113 | PHVS | Pharvaris N.V. | 1.58B | 1.38% | 173,965 | - |
| 114 | ATAI | Atai Beckley N.V. | 1.58B | -1.81% | 2,538,909 | 3.02M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.58B | -1.60% | 565,403 | 44.79M |
| 116 | INVA | Innoviva, Inc. | 1.55B | 0.39% | 528,812 | 388.52M |
| 117 | BHVN | Biohaven Ltd. | 1.53B | 0.70% | 930,138 | - |
| 118 | CAPR | Capricor Therapeutics, Inc. | 1.51B | -3.79% | 1,367,483 | 11.13M |
| 119 | ARDX | Ardelyx, Inc. | 1.50B | 4.32% | 2,283,556 | 398.23M |
| 120 | UPB | Upstream Bio, Inc. | 1.48B | -0.47% | 175,290 | 2.80M |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.48B | 0.99% | 435,654 | - |
| 122 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.44B | 0.46% | 324,452 | -665.00K |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.44B | 5.11% | 135,749 | - |
| 124 | FTRE | Fortrea Holdings Inc. | 1.44B | 0.32% | 555,232 | 2.76B |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.39B | 3.08% | 1,610,127 | 8.36M |
| 126 | SANA | Sana Biotechnology, Inc. | 1.34B | 0.80% | 4,977,763 | - |
| 127 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.33B | -0.12% | 340,515 | 42.34M |
| 128 | PGEN | Precigen, Inc. | 1.30B | 1.80% | 2,223,650 | 6.31M |
| 129 | MBX | MBX Biosciences, Inc. | 1.28B | 0.25% | 133,277 | - |
| 130 | KOD | Kodiak Sciences Inc. | 1.27B | -0.33% | 208,085 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.26B | -0.74% | 169,065 | 169.47M |
| 132 | TNGX | Tango Therapeutics, Inc. | 1.25B | 2.31% | 1,596,767 | 66.50M |
| 133 | MNMD | Mind Medicine (MindMed) Inc. | 1.24B | 0.16% | 593,737 | - |
| 134 | QURE | uniQure N.V. | 1.24B | 0.51% | 1,252,430 | 15.75M |
| 135 | TYRA | Tyra Biosciences, Inc. | 1.22B | 0.24% | 139,844 | - |
| 136 | IMTX | Immatics N.V. | 1.22B | -0.30% | 126,882 | 99.45M |
| 137 | ALMS | Alumis Inc. | 1.20B | -1.12% | 424,245 | 22.12M |
| 138 | OCS | Oculis Holding AG | 1.19B | -1.10% | 64,854 | 992.00K |
| 139 | PHAR | Pharming Group N.V. | 1.19B | 1.38% | 45,380 | 362.27M |
| 140 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | 2.14% | 532,336 | 266.14M |
| 141 | INBX | Inhibrx Biosciences, Inc. | 1.19B | -0.77% | 89,922 | 1.40M |
| 142 | XNCR | Xencor, Inc. | 1.18B | -3.34% | 196,754 | 150.13M |
| 143 | PVLA | Palvella Therapeutics, Inc. | 1.15B | 0.23% | 98,102 | - |
| 144 | CVAC | CureVac N.V. | 1.14B | -0.98% | 415,576 | 83.00M |
| 145 | SEPN | Septerna, Inc. | 1.14B | -3.01% | 80,854 | 22.05M |
| 146 | NKTR | Nektar Therapeutics | 1.14B | 9.31% | 482,481 | 62.60M |
| 147 | NBTX | Nanobiotix S.A. | 1.13B | -2.17% | 26,148 | 11.93M |
| 148 | ABCL | AbCellera Biologics Inc. | 1.11B | -1.07% | 1,924,844 | 35.33M |
| 149 | NTLA | Intellia Therapeutics, Inc. | 1.08B | -2.36% | 1,979,413 | 57.53M |
| 150 | MDXG | MiMedx Group, Inc. | 1.08B | 1.54% | 301,702 | 393.44M |
| 151 | GLUE | Monte Rosa Therapeutics, Inc. | 1.07B | -0.60% | 284,381 | 181.54M |
| 152 | NVAX | Novavax, Inc. | 1.07B | -1.79% | 2,020,069 | 1.06B |
| 153 | MLTX | MoonLake Immunotherapeutics | 1.06B | 5.47% | 1,044,125 | - |
| 154 | SPRY | ARS Pharmaceuticals, Inc. | 1.05B | -5.08% | 1,220,452 | 142.77M |
| 155 | BCAX | Bicara Therapeutics Inc. | 1.04B | 0.42% | 1,830,033 | - |
| 156 | URGN | UroGen Pharma Ltd. | 1.04B | -0.94% | 151,380 | 96.52M |
| 157 | PHAT | Phathom Pharmaceuticals, Inc. | 1.04B | 2.13% | 863,101 | 147.19M |
| 158 | ELVN | Enliven Therapeutics, Inc. | 1.03B | -7.94% | 734,033 | - |
| 159 | RAPT | RAPT Therapeutics, Inc. | 1.02B | 4.83% | 349,708 | - |
| 160 | AVBP | ArriVent BioPharma, Inc. | 1.01B | 0.95% | 106,283 | - |
| 161 | ERAS | Erasca, Inc. | 1.01B | 5.03% | 981,628 | - |
| 162 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 979.86M | -4.60% | 78,022 | - |
| 163 | CMPX | Compass Therapeutics, Inc. | 951.56M | -0.74% | 720,151 | 850.00K |
| 164 | VIR | Vir Biotechnology, Inc. | 933.53M | 1.21% | 693,517 | 16.86M |
| 165 | ORIC | ORIC Pharmaceuticals, Inc. | 923.25M | -2.17% | 425,005 | - |
| 166 | MRVI | Maravai LifeSciences Holdings, Inc. | 923.10M | -2.70% | 968,457 | 192.44M |
| 167 | CRMD | CorMedix Inc. | 917.89M | -0.77% | 2,254,244 | 214.30M |
| 168 | JANX | Janux Therapeutics, Inc. | 917.86M | -0.65% | 921,443 | 10.00M |
| 169 | TBPH | Theravance Biopharma, Inc. | 914.64M | 2.09% | 168,730 | 80.33M |
| 170 | ABUS | Arbutus Biopharma Corporation | 912.58M | 1.61% | 848,717 | 14.61M |
| 171 | MPLT | MapLight Therapeutics, Inc. | 905.56M | 3.26% | 98,324 | - |
| 172 | KURA | Kura Oncology, Inc. | 887.58M | -2.49% | 874,983 | 104.03M |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 887.22M | -0.67% | 8,496,834 | 250.43M |
| 174 | GERN | Geron Corporation | 877.74M | -1.08% | 5,457,292 | 183.40M |
| 175 | YDES | YD Bio Limited | 877.59M | -0.72% | 63,244 | 510.36K |
| 176 | DAWN | Day One Biopharmaceuticals, Inc. | 864.01M | -0.06% | 497,791 | 133.67M |
| 177 | KALV | KalVista Pharmaceuticals, Inc. | 862.83M | 1.01% | 253,046 | 1.43M |
| 178 | IVA | Inventiva S.A. | 853.22M | -0.22% | 45,495 | 19.93M |
| 179 | GOSS | Gossamer Bio, Inc. | 845.97M | 0.97% | 2,150,952 | 44.05M |
| 180 | GHRS | GH Research PLC | 832.12M | -2.79% | 127,178 | - |
| 181 | ARVN | Arvinas, Inc. | 811.15M | 0.48% | 479,535 | 312.30M |
| 182 | REPL | Replimune Group, Inc. | 794.63M | 2.63% | 506,513 | - |
| 183 | VALN | Valneva SE | 751.91M | -0.36% | 4,457 | 211.09M |
| 184 | ANNX | Annexon, Inc. | 751.24M | - | 3,598,049 | - |
| 185 | PRME | Prime Medicine, Inc. | 750.64M | -0.70% | 1,392,630 | 5.98M |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 744.02M | -2.52% | 184,310 | 282.08M |
| 187 | OMER | Omeros Corporation | 739.49M | -1.51% | 570,225 | - |
| 188 | VSTM | Verastem, Inc. | 739.40M | 1.59% | 679,291 | 13.38M |
| 189 | CGEM | Cullinan Therapeutics, Inc. | 739.04M | 1.05% | 338,277 | - |
| 190 | MGTX | MeiraGTx Holdings plc | 738.91M | 5.28% | 810,260 | 27.42M |
| 191 | ATXS | Astria Therapeutics, Inc. | 736.11M | -0.12% | 451,673 | 706.00K |
| 192 | DBVT | DBV Technologies S.A. | 728.56M | -3.55% | 176,367 | 5.50M |
| 193 | LYEL | Lyell Immunopharma, Inc. | 728.53M | 2.77% | 40,366 | 41.00K |
| 194 | LXEO | Lexeo Therapeutics, Inc. | 712.36M | -0.41% | 359,746 | - |
| 195 | GYRE | Gyre Therapeutics, Inc. | 703.49M | -1.65% | 39,326 | 107.27M |
| 196 | FULC | Fulcrum Therapeutics, Inc. | 702.46M | 1.41% | 1,046,280 | 80.00M |
| 197 | RGNX | REGENXBIO Inc. | 700.88M | 7.74% | 323,276 | 161.32M |
| 198 | CTMX | CytomX Therapeutics, Inc. | 698.07M | 1.48% | 712,508 | 113.63M |
| 199 | JBIO | Jade Biosciences, Inc. | 696.04M | 1.95% | 148,897 | - |
| 200 | DRUG | Bright Minds Biosciences Inc. | 693.39M | -3.49% | 56,756 | - |
| 201 | PROK | ProKidney Corp. | 678.38M | 1.58% | 586,442 | 744.00K |
| 202 | KROS | Keros Therapeutics, Inc. | 656.54M | -0.65% | 130,016 | 246.72M |
| 203 | FDMT | 4D Molecular Therapeutics, Inc. | 634.77M | 1.74% | 476,386 | 120.00K |
| 204 | CRVS | Corvus Pharmaceuticals, Inc. | 618.37M | -1.43% | 1,158,058 | - |
| 205 | VTYX | Ventyx Biosciences, Inc. | 586.92M | -3.24% | 390,094 | - |
| 206 | LENZ | LENZ Therapeutics, Inc. | 571.35M | -25.47% | 4,376,697 | 17.50M |
| 207 | ASMB | Assembly Biosciences, Inc. | 569.89M | 0.42% | 109,025 | 37.19M |
| 208 | ENGN | enGene Holdings Inc. | 562.73M | -5.66% | 227,320 | - |
| 209 | IVVD | Invivyd, Inc. | 557.16M | 0.42% | 1,819,641 | 50.04M |
| 210 | ALT | Altimmune, Inc. | 556.67M | -0.09% | 5,174,931 | 20.00K |
| 211 | ABSI | Absci Corporation | 554.12M | -4.04% | 3,307,006 | 2.82M |
| 212 | PRTA | Prothena Corporation plc | 553.37M | -0.48% | 209,305 | 11.79M |
| 213 | DSGN | Design Therapeutics, Inc. | 540.59M | 2.71% | 72,769 | - |
| 214 | DNA | Ginkgo Bioworks Holdings, Inc. | 535.97M | -4.75% | 590,798 | 180.61M |
| 215 | EVMN | Evommune, Inc. | 532.37M | -10.11% | 53,273 | 13.00M |
| 216 | NAGE | Niagen Bioscience, Inc. | 530.19M | -0.15% | 322,987 | 124.71M |
| 217 | ADCT | ADC Therapeutics SA | 522.76M | 0.96% | 493,290 | 75.21M |
| 218 | BCYC | Bicycle Therapeutics plc | 518.18M | 0.54% | 110,958 | 28.34M |
| 219 | MNPR | Monopar Therapeutics Inc. | 507.48M | -1.44% | 129,475 | - |
| 220 | DMAC | DiaMedica Therapeutics Inc. | 488.49M | 0.43% | 476,368 | - |
| 221 | LXRX | Lexicon Pharmaceuticals, Inc. | 481.50M | 0.38% | 649,323 | 70.86M |
| 222 | LBRX | LB Pharmaceuticals Inc | 477.39M | -6.72% | 290,928 | - |
| 223 | ZVRA | Zevra Therapeutics, Inc. | 470.93M | -0.30% | 385,526 | 84.39M |
| 224 | ANRO | Alto Neuroscience, Inc. | 464.78M | 1.91% | 128,302 | - |
| 225 | NBP | NovaBridge Biosciences | 458.76M | 1.53% | 206,858 | - |
| 226 | SLDB | Solid Biosciences Inc. | 458.11M | 0.17% | 442,229 | - |
| 227 | OCGN | Ocugen, Inc. | 432.56M | 6.54% | 2,839,076 | 5.37M |
| 228 | TENX | Tenax Therapeutics, Inc. | 431.67M | 8.02% | 147,871 | - |
| 229 | ENTA | Enanta Pharmaceuticals, Inc. | 429.76M | 5.30% | 113,848 | 65.32M |
| 230 | DRTS | Alpha Tau Medical Ltd. | 429.73M | 1.61% | 138,922 | - |
| 231 | AUTL | Autolus Therapeutics plc | 427.16M | 0.94% | 2,566,144 | 51.13M |
| 232 | BNTC | Benitec Biopharma Inc. | 418.37M | -4.67% | 132,045 | - |
| 233 | AURA | Aura Biosciences, Inc. | 417.22M | 0.92% | 76,557 | - |
| 234 | LCTX | Lineage Cell Therapeutics, Inc. | 409.53M | -1.17% | 532,967 | 10.82M |
| 235 | VTVT | vTv Therapeutics Inc. | 407.51M | -3.70% | 3,827 | 17.00K |
| 236 | IMRX | Immuneering Corporation | 399.69M | -0.16% | 296,398 | - |
| 237 | GALT | Galectin Therapeutics Inc. | 399.09M | 8.41% | 479,143 | - |
| 238 | PRTC | PureTech Health plc | 398.90M | -0.30% | - | 6.39M |
| 239 | TRDA | Entrada Therapeutics, Inc. | 398.06M | 2.68% | 51,398 | 61.52M |
| 240 | FBRX | Forte Biosciences, Inc. | 396.48M | -1.83% | 184,091 | - |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 396.36M | 8.25% | 905,218 | - |
| 242 | PEPG | PepGen Inc. | 393.58M | -0.26% | 162,419 | - |
| 243 | CLLS | Cellectis S.A. | 388.49M | -8.62% | 149,365 | 82.55M |
| 244 | VNDA | Vanda Pharmaceuticals Inc. | 374.38M | -4.02% | 1,257,569 | 212.07M |
| 245 | RCKT | Rocket Pharmaceuticals, Inc. | 373.37M | - | 791,782 | - |
| 246 | NBY | NovaBay Pharmaceuticals, Inc. | 369.21M | 4.27% | 645,578 | 10.30M |
| 247 | IMMP | Immutep Limited | 368.38M | -2.28% | 314,300 | 3.31M |
| 248 | TECX | Tectonic Therapeutic, Inc. | 366.46M | 0.56% | 72,129 | - |
| 249 | CADL | Candel Therapeutics, Inc. | 356.02M | 0.23% | 1,000,326 | - |
| 250 | ACRS | Aclaris Therapeutics, Inc. | 355.37M | -2.38% | 594,638 | 15.74M |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 349.75M | 3.09% | 334,851 | 33.98M |
| 252 | MREO | Mereo BioPharma Group plc | 349.29M | -2.44% | 1,507,801 | 500.00K |
| 253 | AVXL | Anavex Life Sciences Corp. | 347.56M | -5.35% | 3,928,976 | - |
| 254 | NMRA | Neumora Therapeutics, Inc. | 345.82M | -1.69% | 371,095 | - |
| 255 | ALLO | Allogene Therapeutics, Inc. | 344.96M | -0.97% | 1,717,379 | 22.00K |
| 256 | LRMR | Larimar Therapeutics, Inc. | 343.22M | -0.25% | 394,674 | - |
| 257 | AVTX | Avalo Therapeutics, Inc. | 342.01M | -3.33% | 274,731 | 192.00K |
| 258 | CTNM | Contineum Therapeutics, Inc. | 337.64M | -11.48% | 1,031,953 | - |
| 259 | CYBN | Cybin Inc. | 331.11M | 5.32% | 673,562 | - |
| 260 | NGNE | Neurogene Inc. | 330.09M | 0.24% | 54,006 | 925.00K |
| 261 | ACIU | AC Immune SA | 328.49M | 3.11% | 1,843,830 | 5.48M |
| 262 | EPRX | Eupraxia Pharmaceuticals Inc. | 325.66M | -2.34% | 59,890 | - |
| 263 | XOMA | XOMA Royalty Corporation | 318.25M | -3.17% | 79,118 | 47.11M |
| 264 | RLMD | Relmada Therapeutics, Inc. | 316.07M | 2.86% | 747,881 | - |
| 265 | AARD | Aardvark Therapeutics, Inc. | 313.75M | -7.69% | 200,273 | - |
| 266 | GUTS | Fractyl Health, Inc. | 312.46M | -0.87% | 2,325,728 | 3.00K |
| 267 | OABI | OmniAb, Inc. | 310.94M | - | 359,296 | 21.09M |
| 268 | SLN | Silence Therapeutics plc | 305.13M | 0.31% | 107,819 | 25.83M |
| 269 | PALI | Palisade Bio, Inc. | 298.01M | -9.09% | 3,362,242 | - |
| 270 | SLS | SELLAS Life Sciences Group, Inc. | 295.57M | 3.23% | 3,983,196 | - |
| 271 | TARA | Protara Therapeutics, Inc. | 293.26M | -5.49% | 497,935 | - |
| 272 | CAMP | Camp4 Therapeutics Corporation | 293.01M | 3.99% | 105,795 | 3.80M |
| 273 | ABEO | Abeona Therapeutics Inc. | 292.09M | -2.36% | 703,997 | 400.00K |
| 274 | PBYI | Puma Biotechnology, Inc. | 291.51M | 0.96% | 154,937 | 212.00M |
| 275 | CBIO | Crescent Biopharma, Inc. | 285.72M | -4.54% | 74,581 | - |
| 276 | ALDX | Aldeyra Therapeutics, Inc. | 272.84M | -1.20% | 917,963 | - |
| 277 | PYXS | Pyxis Oncology, Inc. | 269.60M | -1.81% | 212,827 | 2.82M |
| 278 | VOR | Vor Biopharma Inc. | 262.68M | 6.10% | 2,906,686 | - |
| 279 | ZURA | Zura Bio Limited | 260.09M | -0.99% | 288,064 | - |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 258.04M | - | 96,244 | 2.82M |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 257.52M | 0.67% | 29,708 | 38.79M |
| 282 | HRTX | Heron Therapeutics, Inc. | 253.96M | 1.09% | 928,295 | 155.10M |
| 283 | FHTX | Foghorn Therapeutics Inc. | 252.78M | -0.22% | 31,676 | 24.52M |
| 284 | ACHV | Achieve Life Sciences, Inc. | 250.20M | 0.21% | 408,466 | - |
| 285 | AVIR | Atea Pharmaceuticals, Inc. | 248.83M | -0.16% | 125,362 | - |
| 286 | NAUT | Nautilus Biotechnology, Inc. | 248.82M | -0.51% | 94,285 | - |
| 287 | PRQR | ProQR Therapeutics N.V. | 248.61M | - | 402,479 | 18.86M |
| 288 | EDIT | Editas Medicine, Inc. | 245.02M | -1.95% | 1,487,264 | 46.38M |
| 289 | VYGR | Voyager Therapeutics, Inc. | 244.64M | -0.23% | 112,930 | 31.32M |
| 290 | HUMA | Humacyte, Inc. | 244.39M | -0.38% | 1,487,620 | 1.57M |
| 291 | MDWD | MediWound Ltd. | 244.38M | -1.04% | 44,716 | 20.93M |
| 292 | MIST | Milestone Pharmaceuticals Inc. | 243.29M | -18.81% | 23,713,811 | - |
| 293 | IMMX | Immix Biopharma, Inc. | 241.93M | -2.37% | 1,122,697 | - |
| 294 | CCCC | C4 Therapeutics, Inc. | 241.80M | -1.77% | 1,076,388 | 30.11M |
| 295 | QNCX | Quince Therapeutics, Inc. | 239.43M | -2.27% | 780,005 | - |
| 296 | CABA | Cabaletta Bio, Inc. | 229.11M | 0.85% | 916,388 | - |
| 297 | TNXP | Tonix Pharmaceuticals Holding Corp. | 227.88M | -1.43% | 304,323 | 10.30M |
| 298 | RNAC | Cartesian Therapeutics, Inc. | 221.81M | 0.95% | 94,834 | 1.09M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 215.37M | 0.80% | 418,177 | 97.60M |
| 300 | ARMP | Armata Pharmaceuticals, Inc. | 209.08M | -0.26% | 23,891 | 5.05M |
| 301 | GANX | Gain Therapeutics, Inc. | 207.57M | 1.46% | 1,179,224 | - |
| 302 | SGMT | Sagimet Biosciences Inc. | 206.19M | 0.16% | 166,330 | - |
| 303 | CLYM | Climb Bio, Inc. | 205.58M | 31.09% | 6,978,951 | - |
| 304 | SRZN | Surrozen, Inc. | 205.03M | 0.46% | 44,886 | 3.60M |
| 305 | DWTX | Dogwood Therapeutics, Inc. | 204.53M | 7.17% | 63,215 | - |
| 306 | TLSA | Tiziana Life Sciences Ltd | 200.81M | -1.74% | 382,930 | - |
| 307 | STTK | Shattuck Labs, Inc. | 199.96M | -2.17% | 124,287 | 1.00M |
| 308 | NVCT | Nuvectis Pharma, Inc. | 195.06M | 0.46% | 47,168 | - |
| 309 | NTHI | NeOnc Technologies Holdings, Inc. | 193.96M | 6.30% | 23,629 | 59.99K |
| 310 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 183.06M | 2.07% | 373,676 | - |
| 311 | SABS | SAB Biotherapeutics, Inc. | 182.33M | 6.69% | 100,588 | 114.70K |
| 312 | IPHA | Innate Pharma S.A. | 180.69M | -2.16% | 19,137 | 14.84M |
| 313 | IKT | Inhibikase Therapeutics, Inc. | 180.36M | 0.98% | 449,783 | 1.00 |
| 314 | ACTU | Actuate Therapeutics, Inc. | 173.16M | 0.40% | 83,300 | - |
| 315 | CRBU | Caribou Biosciences, Inc. | 171.05M | -1.61% | 844,347 | 9.30M |
| 316 | VTGN | Vistagen Therapeutics, Inc. | 170.62M | 9.37% | 450,495 | 721.00K |
| 317 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | -6.12% | 2,432,839 | 1.20M |
| 318 | CHRS | Coherus Oncology, Inc. | 165.59M | -4.20% | 536,395 | 277.73M |
| 319 | IRD | Opus Genetics, Inc. | 165.51M | -1.64% | 198,600 | 14.63M |
| 320 | GNLX | Genelux Corporation | 164.20M | -0.80% | 77,468 | 8.00K |
| 321 | CRDF | Cardiff Oncology, Inc. | 162.68M | -2.42% | 480,347 | 501.00K |
| 322 | ETHZ | ETHZilla Corporation | 161.68M | -6.24% | 759,908 | 4.11M |
| 323 | ALEC | Alector, Inc. | 160.45M | 0.68% | 723,988 | 69.05M |
| 324 | MOLN | Molecular Partners AG | 158.67M | 0.22% | 455 | 856.30K |
| 325 | KLRS | Kalaris Therapeutics, Inc. | 158.41M | 1.68% | 117,884 | - |
| 326 | BDTX | Black Diamond Therapeutics, Inc. | 158.39M | 0.72% | 572,010 | 70.00M |
| 327 | MCRB | Seres Therapeutics, Inc. | 155.67M | 0.28% | 28,735 | 351.00K |
| 328 | SGMO | Sangamo Therapeutics, Inc. | 154.45M | -0.02% | 3,467,591 | 32.88M |
| 329 | CGTX | Cognition Therapeutics, Inc. | 154.04M | 7.72% | 829,637 | - |
| 330 | CDXS | Codexis, Inc. | 153.14M | -0.85% | 444,273 | 52.93M |
| 331 | RZLT | Rezolute, Inc. | 152.07M | 17.14% | 23,676,832 | - |
| 332 | GLSI | Greenwich LifeSciences, Inc. | 148.94M | -4.61% | 133,059 | - |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 146.37M | -0.55% | 357,222 | 61.84M |
| 334 | INO | Inovio Pharmaceuticals, Inc. | 145.99M | -0.23% | 445,404 | 182.34K |
| 335 | SAVA | Cassava Sciences, Inc. | 145.89M | -4.13% | 619,311 | - |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 143.20M | -36.76% | 55,648,245 | - |
| 337 | ELTX | Elicio Therapeutics, Inc. | 142.60M | -2.51% | 19,382 | - |
| 338 | CNTB | Connect Biopharma Holdings Limited | 142.55M | 4.94% | 78,766 | 762.00K |
| 339 | MRSN | Mersana Therapeutics, Inc. | 141.71M | 0.43% | 39,204 | 33.18M |
| 340 | CGEN | Compugen Ltd. | 141.71M | -5.31% | 466,359 | 6.90M |
| 341 | PRLD | Prelude Therapeutics Incorporated | 140.08M | 4.29% | 269,077 | 10.50M |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 134.51M | -2.36% | 176,839 | - |
| 343 | AGEN | Agenus Inc. | 133.31M | -3.92% | 386,294 | 106.83M |
| 344 | NKTX | Nkarta, Inc. | 132.11M | -0.53% | 392,142 | - |
| 345 | SPRO | Spero Therapeutics, Inc. | 131.27M | -0.85% | 211,743 | 40.55M |
| 346 | FATE | Fate Therapeutics, Inc. | 130.92M | 2.25% | 714,101 | 7.14M |
| 347 | ATRA | Atara Biotherapeutics, Inc. | 130.80M | 1.80% | 90,279 | 151.93M |
| 348 | VRCA | Verrica Pharmaceuticals Inc. | 129.68M | -2.29% | 108,047 | 30.83M |
| 349 | EXOZ | eXoZymes, Inc. | 129.58M | -2.83% | 5,044 | -700.00 |
| 350 | COYA | Coya Therapeutics, Inc. | 129.10M | -1.28% | 191,952 | 3.99M |
| 351 | ABOS | Acumen Pharmaceuticals, Inc. | 129.02M | 8.67% | 211,073 | - |
| 352 | ELDN | Eledon Pharmaceuticals, Inc. | 126.25M | -1.18% | 581,992 | - |
| 353 | ORMP | Oramed Pharmaceuticals Inc. | 125.78M | 4.12% | 119,228 | 2.00M |
| 354 | ACOG | Alpha Cognition Inc. | 121.54M | -4.12% | 22,764 | 7.43M |
| 355 | ANIX | Anixa Biosciences, Inc. | 121.46M | -23.13% | 1,936,998 | - |
| 356 | DTIL | Precision BioSciences, Inc. | 121.32M | 2.44% | 89,577 | 698.00K |
| 357 | KPTI | Karyopharm Therapeutics Inc. | 118.84M | -0.43% | 158,223 | 142.53M |
| 358 | OVID | Ovid Therapeutics Inc. | 115.72M | -1.52% | 645,813 | 6.61M |
| 359 | SLGL | Sol-Gel Technologies Ltd. | 114.61M | -2.74% | 9,848 | 18.97M |
| 360 | WHWK | Whitehawk Therapeutics, Inc. | 114.05M | -3.20% | 50,941 | 14.38M |
| 361 | CNTX | Context Therapeutics Inc. | 111.91M | 0.96% | 521,825 | - |
| 362 | ATOS | Atossa Therapeutics, Inc. | 111.40M | -4.69% | 745,571 | - |
| 363 | ANVS | Annovis Bio, Inc. | 109.72M | 9.23% | 746,925 | - |
| 364 | ONCY | Oncolytics Biotech Inc. | 107.74M | 1.66% | 367,384 | - |
| 365 | TTRX | Turn Therapeutics Inc. | 104.24M | 10.28% | 34,043 | - |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 104.04M | -0.69% | 257,648 | 26.87M |
| 367 | BMEA | Biomea Fusion, Inc. | 102.52M | -4.61% | 928,512 | - |
| 368 | VANI | Vivani Medical, Inc. | 100.31M | -1.08% | 157,789 | - |
| 369 | SEER | Seer, Inc. | 99.86M | -1.10% | 212,559 | 16.38M |
| 370 | ENTX | Entera Bio Ltd. | 99.05M | -2.26% | 76,011 | 124.00K |
| 371 | PSTV | Plus Therapeutics, Inc. | 93.93M | -5.07% | 5,155,786 | 5.26M |
| 372 | RPTX | Repare Therapeutics Inc. | 91.99M | - | 498,146 | 11.87M |
| 373 | FBIO | Fortress Biotech, Inc. | 91.87M | 0.68% | 137,377 | 62.30M |
| 374 | ANEB | Anebulo Pharmaceuticals, Inc. | 91.82M | -0.22% | 200 | - |
| 375 | CSBR | Champions Oncology, Inc. | 90.18M | 3.81% | 4,771 | 56.88M |
| 376 | CBUS | Cibus, Inc. | 89.57M | -5.17% | 122,569 | 3.79M |
| 377 | MGNX | MacroGenics, Inc. | 89.19M | - | 413,432 | 127.63M |
| 378 | SPRB | Spruce Biosciences, Inc. | 87.56M | -7.48% | 29,179 | 697.00K |
| 379 | OTLK | Outlook Therapeutics, Inc. | 86.62M | -2.50% | 1,285,017 | 1.51M |
| 380 | VXRT | Vaxart, Inc. | 86.48M | -1.10% | 137,354 | 148.20M |
| 381 | THAR | Tharimmune, Inc. | 84.46M | -4.74% | 137,951 | - |
| 382 | COEP | Coeptis Therapeutics Holdings, Inc. | 84.05M | -3.08% | 69,179 | 501.00K |
| 383 | HYFT | MindWalk Holdings Corp. | 84.00M | -2.67% | 167,632 | 18.21M |
| 384 | ADAG | Adagene Inc. | 83.89M | 0.91% | 4,148 | 103.20K |
| 385 | STRO | Sutro Biopharma, Inc. | 83.52M | - | 52,763 | 105.65M |
| 386 | BYSI | BeyondSpring Inc. | 83.48M | -6.88% | 11,971,723 | 1.88M |
| 387 | KRRO | Korro Bio, Inc. | 81.55M | 9.62% | 294,865 | 7.37M |
| 388 | ALXO | ALX Oncology Holdings Inc. | 81.33M | -1.32% | 71,141 | - |
| 389 | ACET | Adicet Bio, Inc. | 80.85M | -3.25% | 3,267,427 | - |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 80.78M | -1.92% | 304,049 | - |
| 391 | ALGS | Aligos Therapeutics, Inc. | 80.61M | 13.81% | 130,396 | 2.65M |
| 392 | TVGN | Tevogen Bio Holdings Inc. | 79.85M | -6.53% | 554,216 | - |
| 393 | ARTV | Artiva Biotherapeutics, Inc. | 79.03M | 2.55% | 52,108 | 251.00K |
| 394 | PLRX | Pliant Therapeutics, Inc. | 77.73M | -4.17% | 759,029 | - |
| 395 | EQ | Equillium, Inc. | 76.73M | -5.97% | 446,067 | 4.39M |
| 396 | ATYR | aTyr Pharma, Inc. | 76.59M | 2.13% | 970,848 | 190.00K |
| 397 | CRVO | CervoMed Inc. | 76.20M | 0.55% | 8,757 | 6.16M |
| 398 | IMUX | Immunic, Inc. | 76.18M | -3.46% | 995,100 | - |
| 399 | OKYO | OKYO Pharma Limited | 75.97M | -6.48% | 144,915 | - |
| 400 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 75.86M | -2.89% | 2,711,787 | - |
| 401 | MNOV | MediciNova, Inc. | 75.53M | 1.99% | 33,318 | 257.92K |
| 402 | PTHS | Pelthos Therapeutics Inc. | 73.87M | -0.03% | 12,228 | 7.41M |
| 403 | TIL | Instil Bio, Inc. | 73.62M | -0.96% | 32,802 | - |
| 404 | XBIT | XBiotech Inc. | 73.48M | -5.49% | 25,920 | - |
| 405 | IFRX | InflaRx N.V. | 71.36M | 3.26% | 432,763 | 73.73K |
| 406 | IMA | ImageneBio, Inc. | 68.86M | -0.08% | 69,538 | 800.00K |
| 407 | ESLA | Estrella Immunopharma, Inc. | 67.22M | -3.26% | 34,637 | - |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 66.51M | - | 86,599 | - |
| 409 | PYPD | PolyPid Ltd. | 65.54M | -1.01% | 37,349 | - |
| 410 | ATHE | Alterity Therapeutics Limited | 65.24M | -2.47% | 14,504 | 3.57M |
| 411 | LITS | Lite Strategy, Inc. | 64.56M | -3.04% | 172,905 | - |
| 412 | OSTX | OS Therapies Incorporated | 64.09M | -10.34% | 1,179,104 | - |
| 413 | MGX | Metagenomi, Inc. | 64.02M | -2.01% | 302,380 | 30.91M |
| 414 | CALC | CalciMedica, Inc. | 63.40M | -4.14% | 51,471 | - |
| 415 | NTRB | Nutriband Inc. | 59.92M | -0.83% | 8,332 | 2.28M |
| 416 | NRXP | NRx Pharmaceuticals, Inc. | 59.01M | -4.55% | 383,856 | 242.00K |
| 417 | IOBT | IO Biotech, Inc. | 58.93M | -3.65% | 229,741 | - |
| 418 | TCRX | TScan Therapeutics, Inc. | 58.73M | -3.27% | 280,828 | 8.42M |
| 419 | INKT | MiNK Therapeutics, Inc. | 57.88M | -1.75% | 9,385 | - |
| 420 | ICCC | ImmuCell Corporation | 54.77M | -0.25% | 4,101 | 27.77M |
| 421 | INMB | INmune Bio, Inc. | 54.50M | -4.21% | 374,398 | 50.00K |
| 422 | PDSB | PDS Biotechnology Corporation | 53.99M | -2.31% | 433,043 | - |
| 423 | HOWL | Werewolf Therapeutics, Inc. | 52.91M | - | 226,981 | 1.14M |
| 424 | HURA | TuHURA Biosciences, Inc. | 52.54M | -0.97% | 476,479 | - |
| 425 | EVAX | Evaxion A/S | 51.88M | -3.57% | 62,693 | 7.65M |
| 426 | MAIA | MAIA Biotechnology, Inc. | 51.66M | -14.94% | 1,489,106 | - |
| 427 | ABVC | ABVC BioPharma, Inc. | 51.27M | -3.33% | 63,282 | 797.92K |
| 428 | IBO | Impact BioMedical Inc. | 51.00M | -0.12% | 32,384 | 25.00K |
| 429 | CVM | CEL-SCI Corporation | 50.74M | -2.31% | 21,430 | - |
| 430 | JSPR | Jasper Therapeutics, Inc. | 50.51M | -1.90% | 393,160 | - |
| 431 | ANL | Adlai Nortye Ltd. | 50.33M | 6.56% | 42,166 | 1.94M |
| 432 | IPSC | Century Therapeutics, Inc. | 50.01M | -3.18% | 336,020 | 113.34M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 49.68M | -2.36% | 169,165 | - |
| 434 | BCAB | BioAtla, Inc. | 47.75M | 3.70% | 778,627 | 11.00M |
| 435 | PTN | Palatin Technologies, Inc. | 47.18M | 0.32% | 20,281 | 8.85M |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 47.11M | 4.14% | 348,646 | 90.00K |
| 437 | GRCE | Grace Therapeutics, Inc. | 46.62M | -1.79% | 72,413 | - |
| 438 | KZR | Kezar Life Sciences, Inc. | 45.81M | -0.71% | 35,896 | - |
| 439 | CELU | Celularity Inc. | 45.33M | -4.19% | 77,948 | 40.58M |
| 440 | BTAI | BioXcel Therapeutics, Inc. | 44.72M | -1.21% | 337,206 | 752.00K |
| 441 | IBIO | iBio, Inc. | 43.85M | -19.42% | 5,608,670 | 500.00K |
| 442 | OKUR | OnKure Therapeutics, Inc. | 42.41M | -3.10% | 33,850 | - |
| 443 | TVRD | Tvardi Therapeutics, Inc. | 41.93M | -0.45% | 53,381 | - |
| 444 | GLTO | Galecto, Inc. | 41.40M | 7.53% | 60,664 | - |
| 445 | LTRN | Lantern Pharma Inc. | 41.21M | -1.47% | 21,061 | - |
| 446 | RNTX | Rein Therapeutics Inc. | 40.48M | - | 237,415 | - |
| 447 | XCUR | Exicure, Inc. | 40.28M | 4.12% | 147,809 | 500.00K |
| 448 | VERU | Veru Inc. | 39.80M | -3.13% | 75,832 | 16.89M |
| 449 | CUE | Cue Biopharma, Inc. | 38.76M | -0.19% | 183,889 | 7.10M |
| 450 | NXTC | NextCure, Inc. | 38.69M | 0.26% | 31,318 | - |
| 451 | JUNS | Jupiter Neurosciences, Inc. | 38.56M | -5.08% | 21,144 | - |
| 452 | GNTA | Genenta Science S.p.A. | 38.46M | -0.52% | 58,186 | - |
| 453 | QNTM | Quantum BioPharma Ltd. | 38.09M | -4.98% | 13,057 | - |
| 454 | GBIO | Generation Bio Co. | 36.79M | 1.30% | 9,964 | 15.27M |
| 455 | APLM | Apollomics, Inc. | 36.67M | 2.26% | 21,285 | 198.00K |
| 456 | SKYE | Skye Bioscience, Inc. | 35.74M | -3.04% | 143,635 | - |
| 457 | XLO | Xilio Therapeutics, Inc. | 35.65M | -4.41% | 420,673 | 31.80M |
| 458 | DARE | Daré Bioscience, Inc. | 35.58M | 19.14% | 1,564,429 | -57.13K |
| 459 | RADX | Radiopharm Theranostics Limited | 35.38M | -4.99% | 320 | 8.20M |
| 460 | QTTB | Q32 Bio Inc. | 35.38M | -9.59% | 234,651 | - |
| 461 | RNXT | RenovoRx, Inc. | 35.29M | -3.02% | 137,652 | 928.00K |
| 462 | SER | Serina Therapeutics, Inc. | 35.08M | 4.78% | 8,456 | 116.00K |
| 463 | FGEN | FibroGen, Inc. | 34.55M | -1.84% | 4,122 | 8.30M |
| 464 | INTS | Intensity Therapeutics, Inc. | 34.38M | -3.00% | 4,160,971 | - |
| 465 | SNTI | Senti Biosciences, Inc. | 34.31M | -7.77% | 1,140,216 | - |
| 466 | DYAI | Dyadic International, Inc. | 33.52M | 0.29% | 5,084 | 3.34M |
| 467 | ANTX | AN2 Therapeutics, Inc. | 33.16M | 1.68% | 27,012 | - |
| 468 | IGC | IGC Pharma, Inc. | 31.91M | 4.79% | 1,245,990 | 1.11M |
| 469 | PASG | Passage Bio, Inc. | 31.72M | -6.55% | 62,305 | - |
| 470 | LEXX | Lexaria Bioscience Corp. | 31.34M | 14.63% | 326,588 | 705.92K |
| 471 | RLYB | Rallybio Corporation | 31.26M | -0.22% | 27,441 | 674.00K |
| 472 | CING | Cingulate Inc. | 29.93M | 5.98% | 161,473 | - |
| 473 | KLTO | Klotho Neurosciences, Inc. | 29.25M | -4.93% | 757,872 | - |
| 474 | NRXS | NeurAxis, Inc. | 28.76M | 2.66% | 13,405 | 3.36M |
| 475 | NERV | Minerva Neurosciences, Inc. | 28.25M | -1.00% | 16,884 | - |
| 476 | PLUR | Pluri Inc. | 28.13M | -1.62% | 7,122 | 1.33M |
| 477 | BRNS | Barinthus Biotherapeutics plc | 27.81M | -5.47% | 104,455 | 14.97M |
| 478 | BOLD | Boundless Bio, Inc. | 26.18M | 1.70% | 18,107 | - |
| 479 | PLRZ | Polyrizon Ltd. | 25.88M | 5.68% | 303,306 | - |
| 480 | LNAI | Lunai Bioworks Inc. | 25.78M | -5.17% | 200,329 | - |
| 481 | KTTA | Pasithea Therapeutics Corp. | 25.20M | 0.45% | 241,758 | - |
| 482 | HYPD | Hyperion DeFi, Inc. | 24.93M | -7.94% | 303,465 | 345.32K |
| 483 | MRKR | Marker Therapeutics, Inc. | 24.51M | 3.52% | 212,227 | 4.69M |
| 484 | ITRM | Iterum Therapeutics plc | 24.32M | -1.85% | 327,116 | 390.00K |
| 485 | FBLG | FibroBiologics, Inc. | 24.00M | 12.63% | 1,497,231 | - |
| 486 | LIMN | Liminatus Pharma, Inc. | 23.48M | 0.63% | 37,004 | - |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.22M | -3.10% | 27,852 | - |
| 488 | CLGN | CollPlant Biotechnologies Ltd. | 23.19M | -4.47% | 20,273 | 2.48M |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 22.83M | - | 84,008 | - |
| 490 | NNVC | NanoViricides, Inc. | 22.59M | -3.46% | 254,437 | - |
| 491 | NRSN | NeuroSense Therapeutics Ltd. | 22.26M | -0.14% | 103,116 | - |
| 492 | ENLV | Enlivex Therapeutics Ltd. | 21.87M | -6.12% | 687,747 | - |
| 493 | NEUP | Neuphoria Therapeutics Inc. | 21.62M | 1.01% | 91,829 | 15.65M |
| 494 | MTVA | MetaVia Inc. | 21.24M | 12.73% | 61,886 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 21.03M | -1.85% | 164,822 | - |
| 496 | BCTX | BriaCell Therapeutics Corp. | 19.51M | -4.75% | 45,448 | - |
| 497 | KZIA | Kazia Therapeutics Limited | 19.48M | -18.81% | 183,573 | 1.20M |
| 498 | TRAW | Traws Pharma, Inc. | 19.18M | 3.00% | 121,772 | 2.85M |
| 499 | CASI | CASI Pharmaceuticals, Inc. | 19.11M | -0.53% | 9,105 | 26.85M |
| 500 | PMN | ProMIS Neurosciences, Inc. | 19.03M | 1.00% | 7,440 | - |
| 501 | APVO | Aptevo Therapeutics Inc. | 18.96M | -3.02% | 474,591 | - |
| 502 | GDTC | CytoMed Therapeutics Limited | 18.81M | -2.40% | 8,133 | 573.19K |
| 503 | HOTH | Hoth Therapeutics, Inc. | 18.15M | -3.31% | 50,643 | - |
| 504 | ALLR | Allarity Therapeutics, Inc. | 18.10M | -0.43% | 46,451 | - |
| 505 | LSTA | Lisata Therapeutics, Inc. | 18.08M | 0.49% | 7,622 | 1.07M |
| 506 | LPCN | Lipocine Inc. | 17.43M | -1.25% | 15,862 | 4.32M |
| 507 | PULM | Pulmatrix, Inc. | 17.35M | 19.95% | 27,599 | 3.00K |
| 508 | APLT | Applied Therapeutics, Inc. | 17.11M | -45.32% | 33,480,277 | 1.00M |
| 509 | OSRH | OSR Holdings, Inc. | 16.87M | 1.03% | 131,856 | -90.52K |
| 510 | SNGX | Soligenix, Inc. | 16.04M | -2.45% | 94,140 | 2.34K |
| 511 | KAPA | Kairos Pharma, Ltd. | 15.97M | -5.30% | 255,626 | - |
| 512 | CANF | Can-Fite BioPharma Ltd. | 15.97M | -0.83% | 554,530 | 560.00K |
| 513 | NCNA | NuCana plc | 15.90M | -5.68% | 52,466 | - |
| 514 | ATHA | Athira Pharma, Inc. | 15.54M | -0.25% | 10,096 | - |
| 515 | CLRB | Cellectar Biosciences, Inc. | 15.52M | -3.17% | 34,389 | - |
| 516 | TPST | Tempest Therapeutics, Inc. | 15.37M | -1.27% | 28,340 | - |
| 517 | BCDA | BioCardia, Inc. | 15.28M | -2.04% | 29,173 | 3.00K |
| 518 | CRIS | Curis, Inc. | 15.26M | -8.53% | 65,468 | 11.65M |
| 519 | ABP | Abpro Holdings, Inc. | 15.08M | -6.41% | 21,577 | 183.00K |
| 520 | PCSA | Processa Pharmaceuticals, Inc. | 14.86M | -3.53% | 558,052 | - |
| 521 | COCP | Cocrystal Pharma, Inc. | 14.69M | 0.54% | 36,528 | - |
| 522 | AKTX | Akari Therapeutics, Plc | 14.44M | -1.46% | 420,440 | - |
| 523 | CMMB | Chemomab Therapeutics Ltd. | 14.22M | -2.12% | 24,106 | - |
| 524 | NCEL | NewcelX Ltd. | 14.14M | -6.85% | 69,618 | - |
| 525 | BLRX | BioLineRx Ltd. | 13.83M | -1.86% | 9,335 | 12.74M |
| 526 | SYBX | Synlogic, Inc. | 13.08M | 1.61% | 18,117 | 8.00K |
| 527 | LGVN | Longeveron Inc. | 12.82M | -4.13% | 168,912 | 1.44M |
| 528 | IMNN | Imunon, Inc. | 12.77M | 0.73% | 15,064 | - |
| 529 | VYNE | VYNE Therapeutics Inc. | 12.77M | -5.28% | 1,153,789 | 524.00K |
| 530 | EDSA | Edesa Biotech, Inc. | 12.46M | - | 21,768 | - |
| 531 | PHIO | Phio Pharmaceuticals Corp. | 12.27M | 0.01% | 139,620 | - |
| 532 | ICU | SeaStar Medical Holding Corporation | 11.88M | -3.34% | 449,059 | 881.00K |
| 533 | SNSE | Sensei Biotherapeutics, Inc. | 11.22M | -1.17% | 18,734 | - |
| 534 | BOLT | Bolt Biotherapeutics, Inc. | 11.19M | -0.51% | 37,723 | 5.20M |
| 535 | GOVX | GeoVax Labs, Inc. | 11.09M | -3.71% | 290,245 | 3.35M |
| 536 | BIVI | BioVie Inc. | 11.00M | -3.31% | 49,138 | - |
| 537 | CLDI | Calidi Biotherapeutics, Inc. | 10.90M | 1.36% | 28,638 | - |
| 538 | ERNA | Ernexa Therapeutics Inc. | 10.75M | -7.43% | 25,943 | 1,000.00 |
| 539 | APM | Aptorum Group Limited | 10.59M | -2.26% | 24,110 | - |
| 540 | PPCB | Propanc Biopharma, Inc. | 10.47M | -2.85% | 11,102 | - |
| 541 | ASBP | Aspire Biopharma Holdings, Inc. | 10.29M | -8.42% | 28,582,975 | 1.94K |
| 542 | MBRX | Moleculin Biotech, Inc. | 10.28M | 1.00% | 125,825 | - |
| 543 | BRTX | BioRestorative Therapies, Inc. | 9.94M | 1.82% | 7,600 | 383.40K |
| 544 | GRDX | GridAI Technologies Corp. | 9.85M | -6.39% | 41,494 | - |
| 545 | TCRT | Alaunos Therapeutics, Inc. | 9.80M | 2.81% | 25,438 | 6.00K |
| 546 | AEON | AEON Biopharma, Inc. | 9.71M | 7.91% | 186,955 | - |
| 547 | EVGN | Evogene Ltd. | 9.68M | -0.16% | 18,418 | 8.02M |
| 548 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.10M | -4.49% | 28,442 | - |
| 549 | RNAZ | TransCode Therapeutics, Inc. | 8.91M | -6.77% | 15,571 | - |
| 550 | SLXN | Silexion Therapeutics Corp | 8.88M | -6.54% | 17,570 | - |
| 551 | MBIO | Mustang Bio, Inc. | 8.68M | -2.54% | 50,531 | - |
| 552 | ACXP | Acurx Pharmaceuticals, Inc. | 8.63M | 0.73% | 25,004 | - |
| 553 | ALZN | Alzamend Neuro, Inc. | 8.48M | 2.29% | 38,964 | - |
| 554 | CELZ | Creative Medical Technology Holdings, Inc. | 8.32M | 1.81% | 33,250 | 6.00K |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 8.24M | -4.62% | 7,644 | 451.00K |
| 556 | ADXN | Addex Therapeutics Ltd | 8.22M | -3.09% | 5 | 198.82K |
| 557 | PPBT | Purple Biotech Ltd | 8.11M | -7.54% | 422,393 | - |
| 558 | INAB | IN8bio, Inc. | 7.92M | -1.16% | 72,145 | - |
| 559 | KPRX | Kiora Pharmaceuticals, Inc. | 7.78M | -0.93% | 4,017 | 20.00K |
| 560 | KALA | KALA BIO, Inc. | 7.51M | 0.76% | 1,087,315 | - |
| 561 | TOVX | Theriva Biologics, Inc. | 7.47M | -4.86% | 1,691,032 | - |
| 562 | IMRN | Immuron Limited | 7.22M | -1.43% | 32,902 | 4.78M |
| 563 | ADIL | Adial Pharmaceuticals, Inc. | 7.11M | -0.20% | 140,702 | - |
| 564 | BGMS | Bio Green Med Solution, Inc. | 7.11M | -3.33% | 12,112 | 81.00K |
| 565 | LYRA | Lyra Therapeutics, Inc. | 6.98M | -1.75% | 6,882 | 600.00K |
| 566 | GTBP | GT Biopharma, Inc. | 6.92M | 0.09% | 730,629 | - |
| 567 | PMCB | PharmaCyte Biotech, Inc. | 6.86M | -1.06% | 596,064 | - |
| 568 | REVB | Revelation Biosciences, Inc. | 6.75M | -0.87% | 112,742 | - |
| 569 | GNPX | Genprex, Inc. | 6.35M | -13.73% | 356,644 | - |
| 570 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.21M | -8.11% | 19,570 | 15.78K |
| 571 | APRE | Aprea Therapeutics, Inc. | 6.06M | 1.59% | 60,115 | 488.24K |
| 572 | CYCN | Cyclerion Therapeutics, Inc. | 5.79M | -9.52% | 56,214 | 2.86M |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 5.70M | 0.97% | 68,523 | - |
| 574 | SILO | Silo Pharma, Inc. | 5.67M | -4.30% | 166,737 | 72.10K |
| 575 | VIVS | VivoSim Labs, Inc. | 5.58M | -5.31% | 65,069 | 140.00K |
| 576 | JAGX | Jaguar Health, Inc. | 5.57M | -5.56% | 153,955 | 11.79M |
| 577 | XBIO | Xenetic Biosciences, Inc. | 5.53M | -0.24% | 20,058 | 2.86M |
| 578 | ENSC | Ensysce Biosciences, Inc. | 5.26M | 2.05% | 61,664 | 4.49M |
| 579 | MTNB | Matinas BioPharma Holdings, Inc. | 5.08M | -0.04% | 12,823 | - |
| 580 | CNSP | CNS Pharmaceuticals, Inc. | 4.90M | 3.22% | 10,186 | - |
| 581 | HCWB | HCW Biologics Inc. | 4.86M | -8.63% | 156,504 | 422.03K |
| 582 | SLRX | Salarius Pharmaceuticals, Inc. | 4.66M | -1.85% | 93,946 | - |
| 583 | CMND | Clearmind Medicine Inc. | 4.56M | 6.00% | 9,740,842 | - |
| 584 | INDP | Indaptus Therapeutics, Inc. | 4.36M | -3.11% | 9,856 | - |
| 585 | XRTX | XORTX Therapeutics Inc. | 4.21M | - | 16,962 | - |
| 586 | ARTL | Artelo Biosciences, Inc. | 3.86M | -1.49% | 268,930 | - |
| 587 | SCNI | Scinai Immunotherapeutics Ltd. | 3.83M | -2.44% | 14,305 | 1.15M |
| 588 | AZTR | Azitra, Inc. | 3.81M | -2.85% | 43,108 | 7.50K |
| 589 | OGEN | Oragenics, Inc. | 3.80M | -2.07% | 343,207 | - |
| 590 | PHGE | BiomX Inc. | 3.79M | 1.22% | 119,966 | - |
| 591 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.62M | -2.11% | 81,872 | 1.36M |
| 592 | ONCO | Onconetix, Inc. | 3.61M | - | 35,389 | 1.22M |
| 593 | BDRX | Biodexa Pharmaceuticals Plc | 3.41M | -12.70% | 354,720 | 104.90K |
| 594 | ENVB | Enveric Biosciences, Inc. | 3.32M | 2.21% | 256,389 | - |
| 595 | PTIX | Protagenic Therapeutics, Inc. | 3.23M | 5.69% | 97,768 | - |
| 596 | SPRC | SciSparc Ltd. | 3.05M | -1.57% | 122,124 | 1.31M |
| 597 | VRAX | Virax Biolabs Group Limited | 3.04M | 4.62% | 227,694 | 2.99K |
| 598 | ELAB | PMGC Holdings Inc. | 2.88M | -5.84% | 32,607 | 285.95K |
| 599 | CDT | CDT Equity Inc. | 2.87M | -2.76% | 58,806 | - |
| 600 | PBM | Psyence Biomedical Ltd. | 2.81M | -3.23% | 277,818 | - |
| 601 | DRMA | Dermata Therapeutics, Inc. | 2.72M | -3.64% | 32,452 | - |
| 602 | GRI | GRI Bio, Inc. | 1.70M | -1.31% | 1,204,641 | - |
| 603 | MLEC | Moolec Science SA | 1.70M | -2.71% | 13,501 | 7.83M |
| 604 | ADTX | Aditxt, Inc. | 1.26M | -5.06% | 133,836 | 5.95K |